SEC61G and Its Role in Lung Adenocarcinoma
Author Information
Author(s): C Zhou, H Cui, Y Yang, L Chen, M Feng, Y Gao, D Li, L Xiaoqiu, Cao Yiqun
Primary Institution: Fudan University Shanghai Cancer Center
Hypothesis
The SEC61 translocon gamma subunit (SEC61G) is correlated with glycolytic activity, epithelial mesenchymal transition, and the immune suppressive phenotype of lung adenocarcinoma.
Conclusion
SEC61G is a potential prognostic biomarker linked to glycolytic metabolism and the immune-suppressive phenotype in lung adenocarcinoma.
Supporting Evidence
- SEC61G expression is significantly greater in the nonsurviving group than in the surviving group.
- High SEC61G expression is associated with poor prognosis in lung adenocarcinoma.
- SEC61G knockdown markedly inhibits the migration of lung adenocarcinoma cells.
- SEC61G is positively correlated with glycolytic activity as evidenced by increased FDG uptake.
- SEC61G expression is linked to immune cell infiltration in the tumor microenvironment.
Takeaway
This study found that a protein called SEC61G is important for lung cancer and may help doctors understand how to treat it better.
Methodology
The study used bioinformatics analysis and experimental validation, including immunohistochemistry and correlation analysis with clinical data.
Limitations
The study is limited by its sample size and the need for further validation in larger cohorts.
Participant Demographics
Patients with lung adenocarcinoma who underwent surgery at Fudan University Shanghai Cancer Center.
Statistical Information
P-Value
0.018
Confidence Interval
1.050–1.706
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website